From: CD147 and matrix-metalloproteinase-2 expression in metastatic and non-metastatic uveal melanomas
Variable | Total | Metastasis | No metastasis | P-Wert (Spearman’s Rho Test) | |
---|---|---|---|---|---|
p-value | r-value | ||||
Number of patients | 49 | 28 | 21 | ||
Sex | |||||
Female | 21 (42.9 %) | 13 (26.5 %) | 8 (16.3 %) | 0.894 | −0.019 |
Male | 28 (57.1 %) | 15 (30.6 %) | 13 (26.5 %) | ||
LTD (mm) | |||||
Median | 15a | 15.5b | 15b | 0.164 | 0.208 |
Range | 5–30 | 10–30 | 5–28 | ||
Height (mm) | |||||
Median | 7c | 7.5a | 6b | 0.263 | 0.175 |
Range | 2–22 | 2- | 2–12 | ||
Ciliary body invasion | 22d (44.9 %) | 16 (57.1 %) | 6d (28.6 %) | 0.108 | 0.230 |
Scleral invasion | 46d (93.9 %) | 26 (92.9 %) | 20d (95.2 %) | 0.247 | −0.149 |
Extrascleral extension | 7e (14.3 %) | 5d (17.9 %) | 2d (9.5 %) | 0.058 | −0.282 |
Invasion | |||||
of Bruch’s membrane | 27d (55.1 %) | 16 (57.1 %) | 11d (52.4 %) | 0.732 | 0.050 |
of the optic nerve head | 2d (4.1 %) | 1 (3.6 %) | 1d (4.7 %) | 0.560 | −0.088 |
Histological subtype | |||||
Epithelioid | 9 (18.4 %) | 8 (28.6 %) | 0 (0 %) | 0.005 | 0.387 |
Mixed | 22 (44.9 %) | 12 (42.9 %) | 11 (52.4 %) | ||
Spindle cell | 18 (36.7 %) | 8 (28.6 %) | 10 (47.6 %) | ||
TNM | |||||
Stage I | 5f (10.9 %) | 0d (0.0 %) | 5c (26.3 %) | 0.073 | 0.264 |
Stage II | 10 (21.7 %) | 6 (22.2 %) | 4 (21.1 %) | ||
Stage III | 16 (34.8 %) | 11 (40.7 %) | 5 (26.3 %) | ||
Stage IV | 15 (32.6 %) | 10 (37.0 %) | 5 (26.3 %) | ||
High CD105 expression | 26d (54.2 %) | 18d (66.7 %) | 8 (38.1 %) | 0.098 | 0.237 |
High vWF expression | 26 (53.1 %) | 18 (64.3 %) | 8 (21.1 %) | 0.129 | 0.216 |
VM | 25 (51.0 %) | 19 (67. %) | 6 (28.6 %) | 0.016 | 0.342 |